Jinling Pharmaceutical Company Limited

Shenzhen Stock Exchange 000919.SZ

Jinling Pharmaceutical Company Limited Revenue for the year ending December 31, 2023: USD 392.37 M

Jinling Pharmaceutical Company Limited Revenue is USD 392.37 M for the year ending December 31, 2023, a 1.37% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.
  • Jinling Pharmaceutical Company Limited Revenue for the year ending December 31, 2022 was USD 387.05 M, a -12.44% change year over year.
  • Jinling Pharmaceutical Company Limited Revenue for the year ending December 31, 2021 was USD 442.04 M, a 15.24% change year over year.
  • Jinling Pharmaceutical Company Limited Revenue for the year ending December 31, 2020 was USD 383.57 M, a 5.37% change year over year.
  • Jinling Pharmaceutical Company Limited Revenue for the year ending December 31, 2019 was USD 364.01 M, a -13.64% change year over year.
Key data
Date Revenue Gross Profit Operating Income EBIT
Market news
Loading...
Shenzhen Stock Exchange: 000919.SZ

Jinling Pharmaceutical Company Limited

CEO Mr. Yang Wang
IPO Date Nov. 18, 1999
Location China
Headquarters No. 58 Xingang Avenue
Employees 4,871
Sector Health Care
Industries
Description

Jinling Pharmaceutical Company Limited manufactures and sells pharmaceutical products in China. The company offers Mailuoning injection for the treatment of thrombo-occlusive vasculitis, arteriosclerotic occlusive disease, cerebral thrombosis and sequelae, multiple arteritis, acute arterial embolism of the limbs, diabetic gangrene, venous thrombosis, thrombophlebitis, etc.; ferrous succinate tablets for the prevention and treatment of iron deficiency anemia; and lentinan injection for treatment of malignant tumors. It also provides medical health care services. Jinling Pharmaceutical Company Limited is based in Nanjing, China.

Similar companies

000989.SZ

Jiuzhitang Co., Ltd.

USD 1.05

2.82%

000963.SZ

Huadong Medicine Co., Ltd

USD 4.53

2.64%

000999.SZ

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

USD 5.92

1.98%

000952.SZ

Hubei Guangji Pharmaceutical Co., Ltd.

USD 0.77

3.89%

000930.SZ

COFCO Biotechnology Co., Ltd.

USD 0.72

1.75%

StockViz Staff

January 15, 2025

Any question? Send us an email